Dow Down 0.25% Nasdaq Down 0.26%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
13.21 0.42(3.08%) Aug 28, 4:00PM EDT
Prev Close:13.63
Open:13.73
Bid:4.00 x 100
Ask:13.87 x 700
1y Target Est:17.73
Beta:3.29
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:13.17 - 13.93
52wk Range:4.55 - 14.62
Volume:676,724
Avg Vol (3m):1,366,780
Market Cap:947.90M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 3.08%947.90M
GSK117.39B
RHHBY248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback